Your browser doesn't support javascript.
loading
Locally applied statins as adjuvants to non-surgical periodontal treatment for chronic periodontitis: a systematic review and meta-analysis.
Meza-Mauricio, Jonathan; Soto-Peñaloza, David; Peñarrocha-Oltra, David; Montiel-Company, Jose Maria; Peruzzo, Daiane Cristina.
Afiliación
  • Meza-Mauricio J; Department of Periodontology, Guarulhos University, Rua Nilo Peçanha, 68, Guarulhos, SP, Brazil. jomemau60@gmail.com.
  • Soto-Peñaloza D; Stomatology Department School of Medicine and Dentistry, University of Valencia, Valencia, Spain.
  • Peñarrocha-Oltra D; Stomatology Department School of Medicine and Dentistry, University of Valencia, Valencia, Spain.
  • Montiel-Company JM; Stomatology Department School of Medicine and Dentistry, University of Valencia, Valencia, Spain.
  • Peruzzo DC; São Leopoldo Mandic Dental Institute and Research Centre, Campinas, SP, Brazil.
Clin Oral Investig ; 22(7): 2413-2430, 2018 Sep.
Article en En | MEDLINE | ID: mdl-29948277
ABSTRACT

OBJECTIVE:

This review aimed at evaluating the effects of chronic periodontitis (CP) treatment with local statins as adjuncts to scaling and root planing (SRP), compared with SRP alone or with placebo.

METHODS:

Electronic and hand searches were conducted in three databases to select randomized controlled trials (RCTs) comparing SRP + statins versus SRP alone. Random effects models were conducted to determine the clinical attachment level (CAL) gain as the primary outcome variable, and probing pocket depth (PPD) reduction, modified sulcus bleeding index (mSBI), and intrabony defect depth (IBD) as the secondary outcomes.

RESULTS:

Of the 526 papers identified, 15 articles met the criteria for inclusion in this systematic review, and 13 in the meta-analysis. The meta-analysis showed a statistically significant CAL gain (mean differences [MD] = 1.84 mm, 95% confidence interval [CI] = 1.45 to 2.23; p = 0.000), PPD reduction (MD = 1.69 mm, 95% CI = 1.37 to 2.04; p = 0.000), mSBI change (MD = 0.70, 95% CI = 0.57 to 0.84; p = 0.000), and IBD (MD = 1.48, 95% CI = 1.30 to 1.67; p = 0.000) attributed to SRP + statin treatment (6 months).

CONCLUSION:

Within the limitations of this study, the collective evidence emerging from this systematic review and meta-analysis may support the use of locally applied statins as adjuncts to SRP in CP treatment, based on being an easy, low-cost alternative, with lesser adverse effects on bacterial resistance. These results should be interpreted with caution. CLINICAL RELEVANCE Clinicians might consider the use of SRP + statins as an adjunct over other alternative approaches, based on the results of the present review. The informed decision should be taken, considering the patient's values and preferences, and the intervention to be implemented by the clinician.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimioterapia Adyuvante / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Periodontitis Crónica Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Clin Oral Investig Asunto de la revista: ODONTOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quimioterapia Adyuvante / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Periodontitis Crónica Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Clin Oral Investig Asunto de la revista: ODONTOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Brasil